CYP cynata therapeutics limited

CYP Price Target post MSB FDA approval., page-56

  1. 9,343 Posts.
    lightbulb Created with Sketch. 8004
    Horrible hold and disappointments over the years for me, despite being at best a medium position. Loaded up on the low capital raise and felt sick doing so, but remained discipline. CYP a far more pleasant hold from near its lows personally. Why would anyone sell CYP with this news out there?

    Even from a simple DCF analysis or similar perspective, you'd now reduce your approval risks on CYP with the MSB approval news and accordingly raise your forward valuation. Its a boon for the sector, whether you like MSB or not.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.5¢
Change
0.000(0.00%)
Mkt cap ! $39.54M
Open High Low Value Volume
17.5¢ 17.5¢ 17.5¢ $25.82K 147.5K

Buyers (Bids)

No. Vol. Price($)
2 75371 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 73088 2
View Market Depth
Last trade - 11.54am 07/08/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.